BB-301

· Benitec Biopharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BB-301, covering 2025-12-31 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia [Phase 1, Phase 2]

See pricing